Sigyn Therapeutics (SIGY) Non-Current Assets (2016 - 2025)
Sigyn Therapeutics' (SIGY) quarterly Non-Current Assets came in at $50000.0 in Q3 2025, down 68.42% year-over-year from $158330.0 in Q3 2024, and little changed quarter-over-quarter from $50000.0 in Q2 2025.
Powered by 
Analysis
Sigyn Therapeutics (SIGY) Non-Current Assets (2016 - 2025) Analysis & Trends
Sigyn Therapeutics has disclosed Non-Current Assets across 10 years of filings, most recently posting $50000.0 for Q3 2025.
- In Q3 2025, Non-Current Assets fell 68.42% year-over-year to $50000.0; the TTM figure through Sep 2025 stood at $468689.0 (down 35.33% YoY), while the FY2024 annual figure was $192475.0, down 5.53% from the prior year.
- Non-Current Assets came in at $50000.0 for Q3 2025 at Sigyn Therapeutics, roughly flat from $50000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $324291.0 in Q3 2021 to a low of $15806.0 in Q1 2021.
- Average Non-Current Assets over 5 years is $210704.9, with a median of $218352.0 recorded in 2023.
- Year-over-year, Non-Current Assets soared 1821.95% in 2022 and slumped 71.23% in 2025.
- Over 5 years, Non-Current Assets stood at $317228.0 in 2021, then decreased by 17.23% to $262581.0 in 2022, then decreased by 22.41% to $203743.0 in 2023, then dropped by 5.53% to $192475.0 in 2024, then plunged by 74.02% to $50000.0 in 2025.
- Per Business Quant data, the three most recent Non-Current Assets figures were $50000.0 in Q3 2025, $50000.0 in Q2 2025, and $176214.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 50,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 176,214.00 |
| Dec 31, 2024 | 192,475.00 |
| Sep 30, 2024 | 158,330.00 |
| Jun 30, 2024 | 173,789.00 |
| Mar 31, 2024 | 188,867.00 |
| Dec 31, 2023 | 203,743.00 |
| Sep 30, 2023 | 218,352.00 |
| Jun 30, 2023 | 233,022.00 |
| Mar 31, 2023 | 247,959.00 |
| Dec 31, 2022 | 262,581.00 |
| Sep 30, 2022 | 276,896.00 |
| Jun 30, 2022 | 290,911.00 |
| Mar 31, 2022 | 303,784.00 |
| Dec 31, 2021 | 317,228.00 |
| Sep 30, 2021 | 324,291.00 |
| Jun 30, 2021 | 319,145.00 |
| Mar 31, 2021 | 15,806.00 |
| Dec 31, 2020 | 23,633.00 |